Showing results (41-50 of 199) with videos related to

Sort By:
Pageof 20
Cellular Signalling|February 3, 2019
Understanding and exploiting cell signalling convergence nodes and pathway cross-talk in malignant brain cancerNok Him Fung, Corrina A Grima, Samuel S Widodo, et al.
Journal of Neurosurgery|May 5, 2018
Association of copeptin, a surrogate marker of arginine vasopressin, with cerebral vasospasm and delayed ischemic neurologic deficit after aneurysmal subarachnoid hemorrhageSandra J Fernandez, Ibraham Barakat, James Ziogas, et al.
International Journal of Molecular Sciences|December 23, 2023
Tonabersat Significantly Reduces Disease Progression in an Experimental Mouse Model of Multiple SclerosisAndrea Kwakowsky, Bhavya Chawdhary, Antonio de Souza, et al.
Cells|November 6, 2019
Therapeutic Targeting of Cancer Stem Cells in Human Glioblastoma by Manipulating the Renin-Angiotensin SystemDavid Ch Tan, Imogen M Roth, Agadha C Wickremesekera, et al.
Experimental Cell Research|August 12, 2018
Epidermal growth factor receptor: Structure-function informing the design of anticancer therapeuticsRuth A Mitchell, Rodney B Luwor, Antony W Burgess
Frontiers in Bioscience (Landmark Edition)|September 30, 2021
The renin-angiotensin system in central nervous system tumors and degenerative diseasesSimon Haron, Ethan J Kilmister, Paul F Davis, et al.
International Reviews of Immunology|October 8, 2024
Transforming growth factor-β in tumor microenvironment: Understanding its impact on monocytes and macrophages for its targetingTetiana Hourani, Amit Sharma, Rodney B Luwor, et al.
Cells|January 26, 2024
A New Systemic Disease Mouse Model for Glioblastoma Capable of Single-Tumour-Cell DetectionThomas M B Ware, Rodney B Luwor, Hong-Jian Zhu
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|March 29, 2021
Temporal patterns of visual recovery following pituitary tumor resection: A prospective cohort studyMichael T M Wang, James King, R C Andrew Symons, et al.
Molecular and Cellular Biochemistry|October 27, 2022
Repurposing FDA-approved drugs as inhibitors of therapy-induced invadopodia activity in glioblastoma cellsDylan Jones, Clarissa A Whitehead, Marija Dinevska, et al.
Pageof 20